May 20, 2026 — RNews

#reverse transcriptase — Wednesday, May 20, 2026 (1 items)

hot top new

← prev day next day →

0

Antiretroviral Activity, Pharmacokinetics, and Safety of MK-8527, an Oral Nucleoside Reverse Transcriptase Translocation Inhibitor, in Adults With HIV-1 Who Had Not Previously Taken Antiretroviral Agents: Results From 2 Open-Label, Phase 1 Studies. (academic.oup.com)

Carstens RP … Gillespie GL Clinical Infectious Diseases 2026-05-20

#pharmacokinetics #clinical trial #hiv #reverse transcriptase